We determined the age-related prevalence of complement-fixing antibody to Mycoplasma pneumoniae from the computerized laboratory results of our routine diagnostic department. The material consisted of about 58,000 sera from an 8-year period, 1971 to 1978. Among children less than 1 month old, the frequency of complement-fixing antibody of titers -8 was low (23%), and no decrease representing loss of maternal antibody was seen thereafter. An unexpectedly early increase in the antibody prevalence up to 62% was seen by 6 months of age. The frequency of antibody was high among young children from the age of 4 months, in whom symptomatic infection due to M. pneumoniae is rare. The frequency of higher titers (.32) and the geometric mean titer increased more slowly, coinciding with the known age distribution of symptomatic M. pneumoniae disease; the frequency of high titers and the geometric mean titer peaked at the age of 7 to 10 years. Two explanations for the high frequency of complement-fixing antibody to M. pneumoniae in young children are discussed. It may be due to an asymptomatic infection caused by M. pneumoniae or to a nonspecific stimulus by lipids of other organisms, plants, or tissues leading to production of antibodies crossreacting with M. pneumoniae, or it may be due to both of the above. During the study, two extensive epidemics due to M. pneumoniae occurred in Finland, but the prevalence of complement-fixing antibody bore no correlation with these peaks of occurrence.
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The age distribution of symptomatic illness caused by Mycoplasma pneumoniae, one of the most common causative agents of pneumonia, is peculiar, with the incidence being highest among school-age children and young adults (14, 15, 21; G. Biberfeld, Ph.D. thesis, Karolinska Institutet, Stockholm, 1971). Thus, M. pneumoniae pneumonia is commonest in the age groups with the lowest total incidence of pneumonias (14) . However, several studies have revealed that even infants and preschool children often have antibodies to M. pneumoniae (10, 15, 19, 21, 32, 33) . The frequency of antibodies varies widely according to the test used. By sensitive mycoplasmacidal and radioimmunoprecipitating antibody tests, Brunner et al. (4) showed an unexpectedly high frequency of mycoplasmal antibodies among young children hospitalized in Washington, D.C., although when measured by the metabolism inhibition test, the frequency was low.
In this paper, we describe the age-related prevalence of complement-fixing (CF) antibody to M. pneumoniae obtained from the computer-ized results of some 58,000 screening tests performed at our routine diagnostic laboratory during an 8-year period, with emphasis on the frequency of the antibody among infants and young children and its age and titer distributions during the different years. Jansson (20) . Lipid extraction of the antigen was performed as described previously by Kenny and Grayston (22) .
MATERIALS AND METHODS

Patients
RESULTS
Age-related prevalence of antibody. The prevalence of CF antibody to M. pneiumoniae (titer -8) among infants under 1 month old was 23%, i.e., significantly less than among adults 20 to 40 years old (58 to 67%) (groups which include females of childbearing age) ( Table 1 ). The proportion of positive reactors in the next age group, 1 to 3 month olds, was the same, and there was no decrease reflecting the disappearance of transplacentally acquired maternal antibodies. In fact, even among 4 to 6 month olds the prevalence increased sharply, being 62% in this age group.
In the age groups between 7 months and 20 years, the prevalence of antibody remained constant, varying between 73 and 77%. The frequency was highest among 7 to 10 year olds. After the age of 20, the prevalence declined steadily, being about 50% among 50 year olds and 35% among over 80 year olds.
The frequency of higher antibody titers (-32) and the geometric mean titers increased more slowly than the total prevalence of measurable titers, and they peaked at the age of 7 to 10 years (Table 1) . Thus, *the prevalence of high titers obviously corresponds to the age distribution of symptomatic M. pnellmoniae infection.
Yearly distribution of antibody pattern. The age-related prevalence patterns of M. pneiumoniae antibody were unchanged in the four 2-year periods (Fig. 1 (4, 13) . This is supported by the finding of Fernald et al. (13) that 74% of M. pneumoniae infections among children in a daycare center were asymptomatic. Also, the isolation rate of M. pneumoniae from infants and preschool children with respiratory disease is almost indentical with that from the same age group free of respiratory disease: 3.1 and 3.0%, respectively. According to Brunner et al. (4) , this similarity suggests that in this age group the organism does not cause respiratory illness. These findings have led to a suggestion that disease caused by M. pneumoniae may be in part immunologically determined in a host sensitized by one or more silent infections (4, 13) .
Another alternative or concomitant possibility is that the elevations in M. pneumoniae antibody titers in young children are often nonspecific and caused by other organisms or factors. Various degrees of relatedness have been observed in the antigenic composition of different mycoplasmas, principally among arginine-utilizing species (27) . However, M. pneumoniae is thought to be serologically distinct from all other human mycoplasmas even when tested with less specific techniques such as the CF and indirect hemagglutination tests (26) . M. pneumoniae has been shown to have antigenic components similar to glycolipids from MG strain streptococci and to lipids from selected strains of group A streptococci and Staphylococcus aureus (4, 25) , as well as to glycolipids from parsnips, carrots, and spinach (17, 25 (4) showed them to be capable of killing M. pneumoniae in the presence of complement. Circulating antibodies do not, however, significantly prevent natural or experimental infection with M. pneumoniae, although they may prevent the spread of these organisms from the respiratory epithelium to the other tissues (3, 6, 11, 16) . The resistance to infection is obviously more dependent on the local immunological defense of the respiratory tract. In the present study, no correlation was observed between the prevalence of antibodies in low titers and the epidemic occurrence of M. pneumoniae.
CF antibodies often persist in the serum for several years after M. pneumoniae infection (1, 24) , but gradually disappear with time. Because over 60% of the children tested had developed antibody by the age of 4 to 6 months and the prevalence of antibody was still over 50% until the age of 50 years, it is obvious that boostering of the mycoplasmal antibody occurs with time, owing to specific reinfections or to the abovementioned nonspecific mechanisms, or both.
Recently, new sensitive enzyme immunological techniques which can use the protein antigen of M. pneumoniae have been presented (5, 30) . Seroepidemiological studies with these tests may possibly show whether the elevations in M. pneumoniae antibody titers commonly observed among infants and preschool children by older methods are nonspecific and caused by various naturally occurring glycolipids.
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